B. Hosmane

发表

Operations safety: an assessment of a commercial aviation safety program

K. McFadden, B. Hosmane, 2001 .

Antihypertensive and Metabolic Effects of Concomitant Administration of Terazosin and Methyclothiazide for the Treatment of Essential Hypertension

H. Black, R. Grimm, J. Pool, 1992, Journal of clinical pharmacology.

Atrasentan, a n E ndothelin-Recep tor A ntagonist f or Refractory A denocarcinomas: S afety a nd P harmacokinetics

J. Nelson, M. Carducci, R. Donehower, 2013 .

Crossover Versus Parallel Designs: Dose-Escalation Design Comparisons for First-In-Human Studies

B. Hosmane, Zhiwu Yan, Charles Locke, 2013, Journal of biopharmaceutical statistics.

Application of Exposure-Response Analyses to Establish the Pharmacodynamic Similarity of a Once-Daily Regimen to an Approved Twice-Daily Dosing Regimen for the Treatment of HCV Infection

P. Marroum, B. Hosmane, D. Cohen, 2017, The AAPS Journal.

CA-125 KELIM as a Potential Complementary Tool for Predicting Veliparib Benefit: An Exploratory Analysis From the VELIA/GOG-3005 Study

E. Swisher, P. Ansell, R. Coleman, 2022, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Pharmacokinetic and Exposure–Response Analyses of Leuprolide Following Administration of Leuprolide Acetate 3-Month Depot Formulations to Children with Central Precocious Puberty

B. Hosmane, N. Mostafa, K. Chwalisz, 2014, Clinical Drug Investigation.

On shrinkage estimation of the exponential location parameter

N. Ebrahimi, B. Hosmane, 1987 .

Some conditions for optimality of the almost unbiased estimators of regression coefficients

B. Hosmane, 1987 .

Using lower trophic level factors to predict outcomes in classical biological control of insect pests

B. A. Hawkins, B. Hosmane, H. Cornell, 2005 .

Atrasentan, an endothelin-receptor antagonist for refractory adenocarcinomas: safety and pharmacokinetics.

J. Nelson, M. Carducci, R. Donehower, 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Randomized, Placebo-Controlled, Double-Blind, Parallel Design Trial of the Efficacy and Safety of Zestra® in Women With Mixed Desire/Interest/Arousal/Orgasm Disorders

J. Heiman, B. Hosmane, D. Ferguson, 2010, Journal of sex & marital therapy.

Use of Early Clinical Trial Data to Support Thorough QT Study Waiver for Upadacitinib and Utility of Food Effect to Demonstrate ECG Assay Sensitivity

B. Hosmane, P. Jiang, A. Othman, 2017, Clinical pharmacology and therapeutics.

On a generalized stein estimator of regression coefficients

B. Hosmane, 1988 .

The Relationship between Terazosin Dose and Blood Pressure Response in Hypertensive Patients

B. Hosmane, R. Achari, Robert O’Dea, 2000, Journal of clinical pharmacology.

QT Interval: Correction for Heart Rate

Balakrishna Hosmane, B. Hosmane, Charles Locke, 2006 .

A Simulation Study of Power in Thorough QT/QTc Studies and a Normal Approximation for Planning Purposes

B. Hosmane, Charles Locke, 2005 .

Optimal allocation of patients in titration to fixed dose trials

B. Hosmane, Sudhir Gupta, Murari Singh, 2002 .

Improved likelihood ratio tests and pearson chi-square tests for independence in two dimensional contingency tables

B. Hosmane, 1986 .

The Joint Modeling of Drug and Positive Control Effects to Estimate Sample Size and Power in Crossover “Thorough” QT/QTc Studies

B. Hosmane, Y. Chiu, Charles Locke, 2013, Journal of biopharmaceutical statistics.

Sample Size and Power Estimation in Thorough QT/QTc Studies with Parallel Group Design

B. Hosmane, Y. Chiu, Charles Locke, 2010, Journal of biopharmaceutical statistics.

Results of a phase I, open-label, randomized, crossover study evaluating the effects of linifanib on QTc intervals in patients with solid tumors

P. LoRusso, B. Hosmane, Y. Chiu, 2013, Cancer Chemotherapy and Pharmacology.

Quality of Life: Design and Analyses Issues in Clinical Trials

B. Hosmane, Charles Locke, D. Morris, 2004 .

Construction of the flow rate nomogram using polynomial regression.

B Hosmane, C Maurath, M McConnell, 1993, Computer methods and programs in biomedicine.

29 Quality-of-life: Statistical validation and analysis an example from a clinical trial

Balakrishna Hosmane, Clement Maurath, Richard Manski, 2000, Bioenvironmental and public health statistics.

Exposure Adjusted Continuous Reassessment Method (EACRM) - an Adaptive Design Incorporating Time to Toxicity Event for Phase I DoseFinding Studies.

B. Hosmane, W. Munasinghe, Y. Chiu, 2015 .

Exposure–Response Analysis in Oncology Trials

B. Hosmane, Y. Chiu, 2018, Statistical Approaches in Oncology Clinical Development.

Global Analysis of Models for Predicting Human Absorption: QSAR, In Vitro, and Preclinical Models.

B. Hosmane, S. Doktor, J. C. Kalvass, 2021, Journal of medicinal chemistry.

Population Analyses of Efficacy and Safety of ABT-594 in Subjects with Diabetic Peripheral Neuropathic Pain

S. Dutta, B. Hosmane, W. Awni, 2012, The AAPS Journal.

ABT‐335, the Choline Salt of Fenofibric Acid, Does Not Have a Clinically Significant Pharmacokinetic Interaction With Rosuvastatin in Humans

B. Hosmane, W. Awni, T. Zhu, 2009, Journal of clinical pharmacology.

On the asymptotic bias and mean squared error of an improved estimator for coefficients in linear regression

B. Hosmane, 1986 .

An empirical investigation of chi-square tests for the hypothesis of no three-factor interaction in I × J×K contingency tables

B. Hosmane, 1987 .